Drug Trial Radar · NCT00129766
Study of MEDI-524 (Motavizumab) for the Prophylaxis of Serious Respiratory Syncytial Virus (RSV) Disease in High-Risk Children
Last checked: Nov 20, 2026Latest source record: Aug 28, 2013 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
6,635
Actual
Start
Nov 2004
Primary completion
May 2006
Study completion May 2006
Sponsor
- Lead sponsor
- MedImmune LLCAstraZeneca (AZN)
- Sponsor type
- Industry
- First posted
- Aug 12, 2005
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Prevention
- Who can join
- All sexes, up to 24 months
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The primary objective of this study was to compare the safety and efficacy of motavizumab to palivizumab when administered monthly by intramuscular (IM) injection for the reduction of the incidence of RSV hospitalization among children at high risk for serious RSV disease. A secondary objective was to compare the incidence of medically-attended lower respiratory infections (LRIs) between treatment groups.
Conditions
- Respiratory Syncytial Virus Infections
Interventions
motavizumab (MEDI-524)Biological
Motavizumab, 15 mg/kg administered intramuscularly for 5 monthly doses
palivizumabBiological
Palivizumab, 15 mg/kg administered intramuscularly for 5 monthly doses
Primary outcomes
What the sponsor says the trial is designed to measure.
- Incidence of RSV Hospitalization (Includes Deaths by RSV)Time frame: Days 0 - 150
- Number of Participants Reporting Any Adverse Events (AEs)Time frame: Days 0 - 150
- Number of Participants Reporting Any Related AEsTime frame: Days 0 - 150
- Number of Participants Reporting Any Serious Adverse Events (SAEs)Time frame: Days 0 - 150
- Number of Participants Reporting Any Related SAEsTime frame: Days 0 - 150
- Number of Participants Reporting AEs by Highest Severity GradeTime frame: Days 0 - 150
- Number of Participants Who Discontinued Study Drug Due to AEsTime frame: Days 0 - 150
- Number of Participants Who DiedTime frame: Days 0 - 150
- Number of Participants Reporting Changes in Vital Signs From BaselineTime frame: Days 0 - 150
Locations
344 sites in 24 countries. Site status is shown where the registry gives one.
University Of Alabama At Birmingham
Birmingham, Alabama
Alabama Neonatal Medicine OC
Pike Road, Alabama
Maricopa Medical Center
Phoenix, Arizona
Central Arkansas Pediatric Clinic, PA
Benton, Arkansas
The Children's Clinic Of Jonesboro, P.A.
Jonesboro, Arkansas
Arkansas Children's Hospital Research Institute
Little Rock, Arkansas
Arkansas Pediatric Clinic
Little Rock, Arkansas
Little Rock Children's Clinic, PA
Little Rock, Arkansas
Miller Children's Hospital
Long Beach, California
Kaiser Permanente Los Angeles
Los Angeles, California
Children's Hospital of Oakland
Oakland, California
Kaiser Permanente Health Care Plan
Oakland, California
Children's Hospital of Orange County
Orange, California
University of California
San Diego, California
Children's Hospital San Diego
San Diego, California
California Pacific Medical Center
San Francisco, California
Santa Clara Valley Medical Center
San Jose, California
Children's Hospital
Denver, Colorado
Connecticut Children's Medical Center
Hartford, Connecticut
Pediatric Pulmonology, LLC
Stamford, Connecticut
A. I. Dupont Hospital For Children
Wilmington, Delaware
Georgetown University Medical Center
Washington D.C., District of Columbia
Children's National Medical Center
Washington D.C., District of Columbia
Shands Hospital At The University Of Florida
Gainesville, Florida
The Nemours Children's Clinic
Jacksonville, Florida
University Of Miami Medical Center
Miami, Florida
Nemours Children's Clinic Biomedical Research
Orlando, Florida
Univ. S. Florida Pediatrics Ambulatory Care Center
Tampa, Florida
Emory University School Of Medicine
Atlanta, Georgia
Georgia Pediatric Pulmonology Associates
Atlanta, Georgia
The Medical College Of Georgia
Augusta, Georgia
Kapiolani Medical Center for Woman and Children
Honolulu, Hawaii
University of Illinois at Chicago
Chicago, Illinois
Children's Memorial Hospital
Chicago, Illinois
Advocate Hope Children's Hospital
Cook, Illinois
Lutheran General Children's Hospital
Park Ridge, Illinois
James Whitcomb Riley Hospital for Children
Indianapolis, Indiana
Memorial Hospital of South Bend
South Bend, Indiana
University of Louisville
Louisville, Kentucky
Louisiana State University MidCity Clinic
Baton Rouge, Louisiana
Showing 40 of 344 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.